enVVeno Medical Corporation NVNO

Company Overview

enVVeno Medical Corporation is a clinical-stage medical device company focused on the development of implantable solutions for the treatment of chronic venous insufficiency (CVI), a condition that can lead to venous leg ulcers and significant morbidity. The company operates within the medical device and vascular health industries, targeting large unmet needs in venous disease treatment where existing therapies are limited or invasive.

The company’s primary product candidate is the VenoValve, a bioprosthetic venous valve designed to restore competency in deep venous systems of the leg. enVVeno Medical is positioned as a first-mover in the development of a surgically implanted valve specifically designed for venous disease, differentiating it from traditional compression therapies or off-label arterial valve adaptations. The company was founded in 2005 and has evolved from early-stage research into late-stage clinical development, with increasing focus on regulatory approval and commercialization in the United States.